Rutgers Cancer Institute | Strategic Alliance Partners
Latest from Rutgers Cancer Institute
From radiopharmaceuticals to hypofractionated radiation therapy, one expert explained the current landscape of radiation treatments for prostate cancer.
One expert explains how bispecific antibodies are a ‘targeted and effective’ option for patients with multiple myeloma.
Advertisement
Advertisement
Trending on CURE
1
5 Years of Prostate Cancer Advances: A Timeline of FDA Approvals and What They Mean for Patients
2
Getting on My Ovarian Cancer Awareness Soap Box Again Because I Love My Daughter
3
What Your Friend with Cancer REALLY Needs
4
Placebos in Cancer Clinical Trials: What Patients Need to Know
5